MATEO BETANZOS: Open Payments
NPI 1457767998 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 31 payments from 7 companies in 2025. Trend: 2023 $4,620 · 2024 $1,459 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 19 | $582 |
| Gilead Sciences, Inc. | 5 | $137 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Novo Nordisk Inc | 2 | $32 |
| Boston Scientific Corporation | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Biogen, Inc. | 1 | $17 |
Products named: DOVATO, CABENUVA, APRETUDE, Wegovy, General - Thrombectomy, DELSTRIGO, PIFELTRO, PENMENVY.
Industry payments across IL — which companies pay providers there.
